What is our research?

We are developing novel personalized immune-based cancer treatments that are free from chemotherapy.

What is our approach?

We are equipping T cells (white blood cells) with a biosensor (chimeric antigen receptor, CAR) to help them detect and eliminate cancer cells.

Presentations

  • Talk at DGHO 2017, Stuttgart: Critical review on CAR-T
  • Upcoming talk at ESGCT 2017, Berlin 17-20 October
  • Upcoming presentations at ASH 2017, Atlanta, 9-12 December

Awards